News Teva charged in US price-fixing investigation The US Department of Justice has charged Teva with conspiring with other pharma companies to fix prices for generic drugs.
News Lilly pledges £279m to UK for biotech hub and obesity plan Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges including obesity.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.